News and Views


Nature Biotechnology 27, 821 - 823 (2009)
doi:10.1038/nbt0909-821

Silencing prostate cancer

Ivanka Toudjarska1 & Antonin de Fougerolles1

  1. Ivanka Toudjarska and Antonin de Fougerolles are at Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA.

Correspondence to: Antonin de Fougerolles1 e-mail: tdefougerolles@alnylam.com


Systemic delivery of an siRNA–aptamer chimera leads to prostate cancer regression in mice.

Top


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

All in the RNA family

Nature Biotechnology News and Views (01 Aug 2006)


Extra navigation

Open Innovation Challenges

ADVERTISEMENT